Il y a eu 50 transactions d'initiés récentes enregistrées pour Blueprint Medicines Corporation (BPMC), dont 18 achats et 32 ventes. Le total des achats d'initiés s'élève à $78.81M et le total des ventes d'initiés à $8.99M.
Les initiés notables ayant une activité récente comprennent Borisy Alexis, Seely Lynn, Beckman Daniella. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — BPMC
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2025-06-18 |
Borisy Alexis |
Director |
Attribution de RSU |
3,902 |
$128.12 |
$499.92K |
78,062 |
| 2025-06-18 |
Seely Lynn |
Director |
Attribution de RSU |
3,902 |
$128.12 |
$499.92K |
17,156 |
| 2025-06-18 |
Beckman Daniella |
Director |
Attribution de RSU |
3,902 |
$128.12 |
$499.92K |
14,744 |
| 2025-06-18 |
Goldberg Mark Alan |
Director |
Attribution de RSU |
3,902 |
$128.12 |
$499.92K |
22,156 |
| 2025-06-18 |
Coats Lonnel |
Director |
Attribution de RSU |
3,902 |
$12,812.00 |
$49.99M |
6,144 |
| 2025-06-18 |
Albers Jeffrey W. |
Director |
Attribution de RSU |
3,902 |
$128.12 |
$499.92K |
150,532 |
| 2025-06-18 |
Dable Habib J |
Director |
Attribution de RSU |
3,902 |
$128.12 |
$499.92K |
12,644 |
| 2025-06-18 |
Tsai John |
Director |
Attribution de RSU |
3,902 |
$128.12 |
$499.92K |
12,644 |
| 2025-06-03 |
Carter Percy H. |
Chief Scientific Officer |
Vente Informative |
2,418 |
$127.88 |
$309.21K |
54,206 |
| 2025-05-27 |
Albers Jeffrey W. |
Director |
Exercice d'Options (Vente) |
5,000 |
$36.05 |
$180.25K |
92,500 |
| 2025-05-19 |
Rossi Christina |
Chief Operating Officer |
Vente Informative |
57 |
$101.72 |
$5.8K |
64,718 |
| 2025-05-05 |
Rossi Christina |
Chief Operating Officer |
Vente Informative |
144 |
$103.56 |
$14.91K |
66,992 |
| 2025-05-05 |
Hurley Ariel |
Principal Accounting Officer |
Exercice d'Options (Vente) |
2,752 |
$54.13 |
$148.97K |
2,751 |
| 2025-04-01 |
Haviland Kate |
Chief Executive Officer |
Vente Informative |
100 |
$88.59 |
$8.86K |
165,929 |
| 2025-03-24 |
Rossi Christina |
Chief Operating Officer |
Vente Informative |
2,274 |
$95.02 |
$216.08K |
69,266 |
| 2025-03-12 |
Albers Jeffrey W. |
Director |
Exercice d'Options (Vente) |
7,500 |
$36.05 |
$270.38K |
97,500 |
| 2025-03-06 |
Hewes L. Becker |
Chief Medical Officer |
Vente Informative |
2,541 |
$87.98 |
$223.56K |
30,419 |
| 2025-03-05 |
Landsittel Michael |
Chief Financial Officer |
Vente Informative |
5,284 |
$88.80 |
$469.22K |
72,924 |
| 2025-03-05 |
Haviland Kate |
Chief Executive Officer |
Vente Informative |
16,151 |
$88.80 |
$1.43M |
168,427 |
| 2025-03-05 |
Mccain Tracey L |
EVP and Chief Legal Officer |
Vente Informative |
5,262 |
$88.80 |
$467.27K |
66,583 |
| 2025-03-05 |
Rossi Christina |
Chief Operating Officer |
Vente Informative |
6,495 |
$88.80 |
$576.76K |
71,540 |
| 2025-03-05 |
Hurley Ariel |
Principal Accounting Officer |
Vente Informative |
1,326 |
$88.80 |
$117.75K |
16,944 |
| 2025-03-05 |
Durso-bumpus Debra |
Chief People Officer |
Vente Informative |
5,157 |
$88.80 |
$457.94K |
49,606 |
| 2025-03-05 |
Namouni Fouad |
President, R & D |
Vente Informative |
6,489 |
$88.80 |
$576.22K |
75,781 |
| 2025-03-05 |
Hewes L. Becker |
Chief Medical Officer |
Vente Informative |
4,863 |
$88.80 |
$431.83K |
35,651 |
| 2025-03-05 |
Lee Philina |
Chief Commercial Officer |
Vente Informative |
3,733 |
$88.80 |
$331.49K |
41,996 |
| 2025-03-05 |
Carter Percy H. |
Chief Scientific Officer |
Vente Informative |
3,530 |
$88.80 |
$313.46K |
56,865 |
| 2025-03-05 |
Albers Jeffrey W. |
Director |
Vente Informative |
5,766 |
$88.80 |
$512.02K |
146,630 |
| 2025-03-03 |
Hurley Ariel |
Principal Accounting Officer |
Vente Informative |
1,075 |
$95.16 |
$102.3K |
18,270 |
| 2025-03-01 |
Landsittel Michael |
Chief Financial Officer |
Attribution de RSU |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Haviland Kate |
Chief Executive Officer |
Attribution de RSU |
70,400 |
$96.57 |
$6.8M |
70,400 |
| 2025-03-01 |
Mccain Tracey L |
EVP and Chief Legal Officer |
Attribution de RSU |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Rossi Christina |
Chief Operating Officer |
Attribution de RSU |
26,400 |
$96.57 |
$2.55M |
26,400 |
| 2025-03-01 |
Hurley Ariel |
Principal Accounting Officer |
Attribution de RSU |
7,007 |
$96.57 |
$676.67K |
7,007 |
| 2025-03-01 |
Durso-bumpus Debra |
Chief People Officer |
Attribution de RSU |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Namouni Fouad |
President, R & D |
Attribution de RSU |
26,400 |
$96.57 |
$2.55M |
26,400 |
| 2025-03-01 |
Hewes L. Becker |
Chief Medical Officer |
Attribution de RSU |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Lee Philina |
Chief Commercial Officer |
Attribution de RSU |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Carter Percy H. |
Chief Scientific Officer |
Attribution de RSU |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-02-20 |
Rossi Christina |
Chief Operating Officer |
Vente Informative |
2,274 |
$95.14 |
$216.35K |
64,835 |
| 2025-01-21 |
Albers Jeffrey W. |
Director |
Exercice d'Options (Vente) |
10,000 |
$36.05 |
$360.5K |
105,000 |
| 2025-01-21 |
Haviland Kate |
Chief Executive Officer |
Vente Informative |
1,446 |
$110.24 |
$159.41K |
149,378 |
| 2025-01-21 |
Rossi Christina |
Chief Operating Officer |
Vente Informative |
121 |
$111.81 |
$13.53K |
67,109 |
| 2025-01-13 |
Albers Jeffrey W. |
Director |
Exercice d'Options (Vente) |
5,000 |
$36.05 |
$180.25K |
115,000 |
| 2025-01-13 |
Hurley Ariel |
Principal Accounting Officer |
Exercice d'Options (Vente) |
2,250 |
$36.05 |
$81.11K |
2,250 |
| 2024-12-19 |
Albers Jeffrey W. |
Director |
Exercice d'Options (Vente) |
15,000 |
$36.05 |
$540.75K |
120,000 |
| 2024-12-18 |
Rossi Christina |
Chief Operating Officer |
Vente Informative |
108 |
$96.50 |
$10.42K |
69,383 |
| 2024-12-12 |
Hurley Ariel |
Principal Accounting Officer |
Exercice d'Options (Vente) |
1,600 |
$15.01 |
$24.02K |
- |
| 2024-11-29 |
Haviland Kate |
Chief Executive Officer |
Vente Informative |
207 |
$97.76 |
$20.24K |
150,824 |
| 2024-11-27 |
Rossi Christina |
Chief Operating Officer |
Vente Informative |
2,274 |
$95.10 |
$216.26K |
71,657 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
